SCHEMBL5445795

SCHEMBL5445795

CNC(=O)COC(=O)N1CCC(O)(c2ccc(-c3ccc(OC)c(F)c3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
CD274 Q9NZQ7 1/20 0.41
FAAH O00519 1/20 0.39
ABHD6 Q9BV23 1/20 0.39
MCHR1 Q99705 1/20 0.38
CYP3A4 P08684 2/20 0.37
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
CYP17A1 P05093 1/20 0.37
JAK2 O60674 1/20 0.37
CACNA1H O95180 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
TDP2 O95551 1/20 0.36
MAPT P10636 1/20 0.36
FFAR1 O14842 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453462 0.86 SMN1; SMN2 (0.46) FAAHPOLB
SCHEMBL5445830 0.85 FAAH (0.46) KDM4EFAAHMCHR1ALDH1A1
SCHEMBL5447927 0.85 SMN1; SMN2 (0.45) KDM4EFAAHMAPTMAPK1ALDH1A1
SCHEMBL5239584 0.83 CD274 (0.45) KDM4ECD274L3MBTL1MAPTMAPK1
SCHEMBL5445764 0.82 FAAH (0.45) FAAHL3MBTL1MAPK1ALDH1A1
SCHEMBL5443508 0.82 FAAH (0.46) KDM4EFAAHL3MBTL1MAPTMAPK1
SCHEMBL5442739 0.81 FAAH (0.57) KDM4EFAAHALDH1A1POLB
SCHEMBL1581921 0.81 KDM4E (0.50) KDM4ECD274ABHD6CYP3A4CYP11B1
SCHEMBL5447955 0.81 FAAH (0.44) FAAHCYP11B1CYP11B2
SCHEMBL5442748 0.80 FAAH (0.47) FAAHCYP3A4L3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021405-A1 ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS FAAH, FAAH2, HRH2 KDM4E 2229/4885CD274 4083/4885FAAH 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.